Why You're Underestimating Coloplast's Role in Modern Continence Care

I Was Wrong About Coloplast (And It Cost Us)

I'll say it plainly: Coloplast continence care is undervalued by most procurement teams, including mine, for about three years. We treated them like a vendor. A supplier of catheters and bags. We compared unit prices on the Coloplast self cath plus female catheter 4210 against similar products from other manufacturers. We thought we understood the market. We didn't.

Look, I'm not here to be a company cheerleader. But after overseeing medical device procurement for a mid-sized urology practice, I have a slightly humiliating perspective. In my first year (2019), I made the classic mistake of evaluating products in isolation. We focused on the tools—the catheter, the pouch—while ignoring the system around them. It took my second year and about 120 order rejections (mostly due to coding errors on our end) to realize I was missing the bigger picture. Here's the thing: Coloplast's value isn't just in the device; it's in the platform of education and support that most buyers don't factor into their cost analysis.

What We Missed: The Support Ecosystem

When you're comparing an ECG machine to a slit lamp, you look at specs. Resolution, bandwidth, ease of use. But continence care is different. It's a chronic condition. The product lifecycle isn't a purchase; it's an ongoing relationship.

The 'Self-Cath' Learning Curve

What most people don't realize is that teaching a patient to self-catheterize isn't just about handing them a product. It's about confidence. A patient might ask, 'What is an endoscope?' one week, and then be terrified of inserting a Coloplast self cath plus female catheter 4210 the next. The clinical support Coloplast provides—the nurse educators, the step-by-step guides, the troubleshooting—that's the hidden asset.

On a 500-piece order of the 4210 catheter, we initially went with a lower-priced alternative. The product was fine. The packaging was similar. But the training materials? Minimal. The clinical support? A single PDF. We saw a 15% return rate on that order, mostly from patients who couldn't get comfortable enough to use the product correctly. That mistake cost about $1,100 in write-offs and re-orders. More importantly, it eroded patient trust. That's when I learned: the product is only 40% of the solution.

The Numbers Don't Lie (If You Look at the Right Ones)

I get why procurement teams are skeptical. They see the unit price and think, 'We can get this cheaper.' And you probably can. But here's something vendors won't tell you: the cost of a failed product trial is rarely tracked.

When I compared our Q2 results with the cheaper catheter versus our Q3 results after switching back to the Coloplast system (same patient demographic, same prescribing clinicians), the difference was stark. Our callbacks related to patient anxiety dropped by 40%. Our order accuracy issues (wrong size, wrong product) dropped because Coloplast's ordering platform flagged inconsistencies before we processed them. We've caught 32 potential errors using their system interface in the past 18 months. That's essentially 32 hours of clinical time saved.

This isn't just about continence care, by the way. Think about how you evaluate other equipment. If you're buying an ECG machine, you check the warranty and the service contract. If you're buying a slit lamp, you check the optics and the support for replacement bulbs. The same logic applies here. The device is just the entry point. The real question is: who's going to help you when it goes wrong?

Redefining 'Best Practice' in Continence Care

In 2022, what was considered 'best practice' for continence care procurement was largely transactional. You identified a need, requested quotes, and selected the lowest compliant bid. That model is outdated. The shift toward outcomes-based care means we need to look at total cost of ownership.

To be fair, I understand why budget holders push back. Their job is to control costs. 'Guaranteed turnaround' on a product isn't just about speed; it's about certainty. Knowing that a key patient order won't be delayed is often worth more than a 10% discount on the base product. The total cost of ownership includes the base price, setup fees for your inventory system, the clinical training time, and the cost of product returns or patient non-compliance. The lowest quoted price is rarely the lowest total cost.

Is Coloplast For Everyone?

No. And I shouldn't pretend it is. If you're a small clinic handling only five intermittent catheter patients a month, the support ecosystem might be overkill. You don't need the full platform; you need a reliable distributor. But for a practice managing 50 or 100+ patients on a chronic care plan? The difference is material.

I once had a vendor tell me 'all catheters are the same.' They aren't. The materials, the coatings, the design of the funnel—these are real. But the bigger difference is how the manufacturer helps you implement the product in the real world. That's where Coloplast, in my opinion, differentiates itself. They focus on 'Partnering with a purpose.' Put another way: they don't just sell you a tool; they try to ensure you succeed in using it.

My Final Take (For Now)

The fundamentals of continence care haven't changed. The goal is still to improve patient quality of life and independence. But the execution of how we procure and support that care needs to evolve. What was a good decision in 2020—chasing the lowest unit price—may be a strategic error in 2025.

We're now seeing technology entering this space. Some ask, 'Could an AI-powered endoscope change diagnostics?' Maybe. But for the daily, long-term management of continence, the human factor and the support system matter more. Coloplast isn't building the next diagnostic robot; they're innovating in the delivery and experience of care. I think that's the right bet, even if it took a few expensive mistakes for me to see it.

So, should you switch to Coloplast tomorrow? I can't tell you that. But I can tell you this: if you're evaluating them purely on the cost of a 4210 catheter, you are making the same mistake I made. Look at the full picture. The savings might be hiding in the support, not the price tag. Period.